109 related articles for article (PubMed ID: 1904180)
1. Recombinant alpha-interferons, thyroid irradiation and thyroid disease.
Giles FJ; Worman CP; Jewell AP; Goldstone AH
Acta Haematol; 1991; 85(3):160-3. PubMed ID: 1904180
[TBL] [Abstract][Full Text] [Related]
2. Interferon therapy for lymphoproliferative disorders.
Roth MS; Bunn PA; Foon KA
Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
[No Abstract] [Full Text] [Related]
3. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune thyroid dysfunctions in hematologic malignancies treated with alpha-interferon.
Vallisa D; Cavanna L; Berté R; Merli F; Ghisoni F; Buscarini L
Acta Haematol; 1995; 93(1):31-5. PubMed ID: 7725847
[TBL] [Abstract][Full Text] [Related]
5. Mental depression, acute infection and coma in a patient treated with interferon-alpha.
Russo D; Zuffa E; Bandini G; Baccarani M; Tura S
Haematologica; 1989; 74(2):228. PubMed ID: 2501183
[No Abstract] [Full Text] [Related]
6. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
[TBL] [Abstract][Full Text] [Related]
8. Biological molecules in the treatment of hematological disorders.
Kurzrock R; Talpaz M; Gutterman U
Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
[No Abstract] [Full Text] [Related]
9. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
10. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia.
Wandl UB; Kloke O; Niederle N
Lancet; 1992 Jan; 339(8785):123-4. PubMed ID: 1345846
[No Abstract] [Full Text] [Related]
11. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
[TBL] [Abstract][Full Text] [Related]
12. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa.
Lisker-Melman M; Di Bisceglie AM; Usala SJ; Weintraub B; Murray LM; Hoofnagle JH
Gastroenterology; 1992 Jun; 102(6):2155-60. PubMed ID: 1587439
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature.
Tanaka M; Kimura R; Matsutani A; Zaitsu K; Oka Y; Oizumi K
Acta Haematol; 1998; 99(4):221-3. PubMed ID: 9644301
[TBL] [Abstract][Full Text] [Related]
14. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
Hass HG; Klein R; Nehls O; Kaiser S
J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic myopathy during interferon alfa therapy for chronic myelogenous leukemia.
Falcone A; Bodenizza CA; Musto P; Carotenuto M
Leukemia; 1998 Aug; 12(8):1329. PubMed ID: 9697894
[No Abstract] [Full Text] [Related]
16. Activity of alpha-interferons in chronic myelogenous leukaemia.
Talpaz M
Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
[No Abstract] [Full Text] [Related]
17. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia].
Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE
Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-alpha in therapy of malignant hemoblastoses].
Schuler M; Aulitzky WE; Schneller F; Peschel C; Huber C
Internist (Berl); 1995 Dec; 36(12):1133-8. PubMed ID: 8567218
[No Abstract] [Full Text] [Related]
19. Recombinant alpha-interferon as salvage therapy in multiple myeloma. A pilot study.
Jacobs P; Le Roux IM; Wood L; King HS
S Afr Med J; 1989 Aug; 76(3):100-2. PubMed ID: 2762938
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
